Enzymes

Core Explanation

What Enzymes Are and Why Life Requires Them

An enzyme is a biological catalyst — almost always a protein (with rare exceptions in catalytic RNA, called ribozymes). Enzymes accelerate the rate of a chemical reaction without being consumed in the process. A single enzyme molecule can catalyze thousands or even millions of reaction cycles per second.

Why do cells need enzymes? The answer is thermodynamic necessity. Most reactions required for life are thermodynamically favorable (ΔG < 0) — they could happen spontaneously — but they occur at negligible rates under cellular conditions. A typical biochemical reaction might have a half-life of years if uncatalyzed. Enzymes bridge the gap between thermodynamic possibility and biological reality by dramatically increasing reaction rates — often by factors of 10⁶ to 10¹⁷.

Activation Energy and the Transition State

Every chemical reaction, even a spontaneous one, must pass through a high-energy intermediate configuration called the transition state. The energy required to reach this state is the activation energy (E_a). Think of E_a as the height of a hill that reactants must climb before they can roll down to products:

Energy
  ↑
  |     Transition state (‡)
  |        /\
  |       /  \
  |      / E_a\  ← activation energy (uncatalyzed)
  |     /      \
  |    /  R     \
  |   /          ___ P
  |  └───────────────┘
  |     ΔG (overall free energy change)
  └──────────────────────────→ Reaction coordinate

Reactants (R) must absorb enough energy to reach the transition state (‡), where old bonds are strained or partially broken and new bonds begin to form. Once the transition state is reached, the reaction proceeds to products (P).

Critical distinction: ΔG is the difference in free energy between reactants and products — it tells you whether a reaction is thermodynamically favorable. E_a is the energy barrier along the way — it tells you how fast the reaction will go. A reaction with ΔG = −50 kJ/mol is highly favorable but could still be impossibly slow if the activation energy is enormous.

How Enzymes Work: Lowering Activation Energy

Enzymes accelerate reactions by lowering the activation energy (E_a). They do this by stabilizing the transition state — providing an alternative reaction pathway with a lower energy barrier. This is the only thing enzymes do to the reaction energetics:

Enzymes do NOT change ΔG. Enzymes do NOT change the equilibrium constant (K_eq). Enzymes do NOT make a nonspontaneous reaction spontaneous. They simply make a reaction that would eventually happen reach equilibrium faster.

This principle cannot be overstated. An enzyme lowers E_a, which increases the rate of both the forward and reverse reactions by exactly the same factor. The ratio of rate constants (k_forward / k_reverse = K_eq) remains unchanged. The enzyme neither adds energy to nor extracts energy from the reaction; it only makes the existing thermodynamic landscape more navigable.

Substrates, the Active Site, and the Induced-Fit Model

The molecule an enzyme acts upon is called the substrate. The substrate binds to a specific region of the enzyme called the active site — a pocket or cleft formed by the three-dimensional folding of the polypeptide chain. The active site typically occupies only a small fraction of the enzyme's total surface area.

Two models describe enzyme-substrate binding:

Lock-and-Key Model (Emil Fischer, 1894): The active site has a rigid shape that is exactly complementary to the substrate, like a key fitting into a lock. This model captures the idea of specificity but fails to explain how enzymes stabilize the transition state.

Induced-Fit Model (Daniel Koshland, 1958): When the substrate approaches and begins to bind, the enzyme undergoes a conformational change — the active site wraps around the substrate, molding itself into a complementary shape. This conformational change brings catalytic amino acid side chains into the correct orientation and position to act on the substrate. The induced-fit model is the currently accepted description for most enzymes.

The induced-fit model explains several observations:

• The enzyme is most complementary to the transition state, not the ground-state substrate — this is how it stabilizes the transition state and lowers E_a.
• Binding energy released from enzyme-substrate interactions helps distort the substrate toward the transition-state geometry (a phenomenon sometimes called transition-state stabilization or strain).
• The conformational change upon binding is often the rate-limiting step for regulated enzymes, providing a target for allosteric control.

The catalytic mechanisms enzymes employ include:

• Acid-base catalysis: Amino acid side chains donate or accept protons.
• Covalent catalysis: A transient covalent bond forms between enzyme and substrate.
• Metal ion catalysis: Bound metal ions orient substrates, stabilize charges, or mediate redox reactions.
• Proximity and orientation effects: The enzyme holds substrates in the correct orientation and close proximity, increasing the effective concentration of reactants.

Enzyme Specificity

Enzymes are remarkably specific — most catalyze only a single reaction or a narrow set of closely related reactions. Specificity arises from:

1. Shape complementarity: The active site's three-dimensional architecture matches the substrate's shape. Even stereoisomers are usually distinguished — an enzyme that binds L-amino acids will not bind D-amino acids.

1. Chemical complementarity: Amino acid residues in the active site form specific noncovalent interactions (hydrogen bonds, ionic bonds, hydrophobic contacts) with functional groups on the substrate.

1. Transition-state complementarity: The active site is evolutionarily optimized to bind and stabilize the transition state, not just the ground-state substrate. This is why transition-state analogs — stable molecules that resemble the transition state — are often extremely potent enzyme inhibitors.

The degree of specificity varies:

• Absolute specificity: Catalyzes only one reaction with one substrate (e.g., urease acts only on urea).
• Group specificity: Acts on a functional group or bond type across a family of related substrates (e.g., hexokinase phosphorylates several hexoses).
• Linkage specificity: Acts on a particular type of chemical bond regardless of the rest of the molecule (e.g., proteases cleave peptide bonds, but different proteases recognize different residue contexts).

Cofactors and Coenzymes

Many enzymes require additional non-protein components to function. The protein portion alone is called the apoenzyme; together with its required cofactor, it forms the active holoenzyme.

Cofactors are inorganic ions or metal atoms that participate directly in catalysis:

• Mg²⁺: Required by kinases and many enzymes that use ATP (the true substrate is often Mg-ATP).
• Fe²⁺/Fe³⁺: Found in cytochromes, catalase, and many redox enzymes (often within heme groups).
• Zn²⁺: A catalytic center in carbonic anhydrase and a structural component in zinc-finger DNA-binding proteins.
• Cu²⁺, Mn²⁺, Mo, Se: Present in various oxidoreductases and other enzymes.

Coenzymes are small organic molecules, often derived from vitamins, that shuttle chemical groups between enzymes:

• NAD⁺/NADH (from niacin, vitamin B₃): Carries electrons in redox reactions (dehydrogenases).
• FAD/FADH₂ (from riboflavin, vitamin B₂): Another electron carrier, often tightly bound (prosthetic group).
• Coenzyme A (CoA) (from pantothenic acid, vitamin B₅): Carries acyl groups; central to the citric acid cycle and fatty acid metabolism.
• ATP: The universal energy currency; also a coenzyme that transfers phosphate groups.
• Pyridoxal phosphate (PLP) (from vitamin B₆): Coenzyme for aminotransferases and many amino acid-metabolizing enzymes.
• Thiamine pyrophosphate (TPP) (from vitamin B₁): Coenzyme for decarboxylation reactions.
• Biotin: Coenzyme for carboxylation reactions.
• Tetrahydrofolate (THF) (from folate): Carries one-carbon units in nucleotide and amino acid biosynthesis.

Some coenzymes are cosubstrates — they bind transiently, undergo chemical change, and are regenerated elsewhere (e.g., NAD⁺ is reduced to NADH during one reaction, then reoxidized to NAD⁺ in another). Others are prosthetic groups — they remain tightly or covalently bound to the enzyme throughout the catalytic cycle (e.g., FAD in succinate dehydrogenase, heme in cytochromes).

Temperature and pH Effects on Enzyme Activity

Enzyme activity is exquisitely sensitive to temperature and pH because both affect the weak interactions that maintain protein structure.

Temperature

As temperature increases, two opposing effects compete:

1. Increased kinetic energy: Molecules move faster, collide more frequently, and a greater fraction of collisions have sufficient energy to overcome E_a. This causes the reaction rate to increase — typically a 1.5- to 2-fold rate increase per 10°C (Q₁₀ ≈ 1.5–2.0) within the enzyme's optimal range.

1. Thermal denaturation: Beyond a certain temperature, the thermal energy disrupts the hydrogen bonds, ionic interactions, and hydrophobic packing that maintain the enzyme's three-dimensional structure. The active site loses its shape; substrate binding and catalysis become impossible.

The net result is a characteristic bell-shaped temperature-activity curve. Most human enzymes have temperature optima near 37°C. Some organisms have adapted:

• Thermophilic bacteria (e.g., Thermus aquaticus, source of Taq DNA polymerase) have enzymes with optima above 70°C, stabilized by additional ionic bonds and hydrophobic interactions.
• Psychrophilic organisms have enzymes with high flexibility and activity at near-freezing temperatures.

pH

pH affects enzyme activity by altering the ionization state of amino acid side chains in the active site and throughout the protein:

• Active-site residues: Catalytic mechanisms often depend on specific residues being protonated or deprotonated. For example, a general acid catalyst must be protonated to donate a proton; a general base must be deprotonated to accept one. The wrong ionization state inactivates the enzyme.
• Substrate binding: Changes in charge distribution can prevent the substrate from binding correctly.
• Overall structure: Extreme pH values can protonate or deprotonate numerous residues, disrupting the ionic bonds and salt bridges that stabilize tertiary structure — leading to denaturation.

Each enzyme has a characteristic pH optimum. Pepsin (stomach protease) works best at pH ~2, reflecting its adaptation to the gastric environment. Trypsin (intestinal protease) has an optimum near pH 8. Most intracellular enzymes have optima near pH 7.0–7.5.

Denaturation

Denaturation is the loss of a protein's native three-dimensional structure (secondary, tertiary, and quaternary) without breaking peptide bonds. The primary structure — the amino acid sequence — remains intact. Denaturation is usually irreversible for most enzymes because the folding pathway is kinetically complex and the native state is only marginally stable.

Causes of denaturation include:

• Heat: Disrupts all weak interactions (H-bonds, hydrophobic interactions, van der Waals).
• Extreme pH: Alters charge states of ionizable side chains, disrupting salt bridges.
• Organic solvents: Disrupt hydrophobic interactions that stabilize the protein core.
• Heavy metals (Hg²⁺, Pb²⁺, Ag⁺): Bind to cysteine sulfhydryl groups, disrupting disulfide bonds and structure.
• Detergents (SDS): Disrupt hydrophobic interactions.

Enzyme Inhibition

Enzyme inhibitors are molecules that reduce or abolish enzyme activity. They are essential tools for studying enzyme mechanisms, and many drugs and toxins are enzyme inhibitors.

Competitive Inhibition

A competitive inhibitor resembles the substrate structurally and competes for binding to the active site. It does not undergo catalysis; it simply occupies the active site and prevents substrate access.

Key characteristics:

• Binds reversibly to the active site.
• Can be overcome by increasing substrate concentration — at sufficiently high [S], the substrate outcompetes the inhibitor.
• Effect on kinetics: Increases the apparent K_m (more substrate needed to reach half-maximal velocity) but does NOT change V_max (the same maximum rate can be achieved if [S] is high enough).
• On a Lineweaver-Burk plot, competitive inhibition produces lines that intersect on the y-axis (same V_max, different apparent K_m).

Biological examples:

• Statins (e.g., atorvastatin) competitively inhibit HMG-CoA reductase, blocking cholesterol synthesis. The statin resembles the enzyme's natural substrate, HMG-CoA.
• Methanol poisoning treatment: Ethanol and methanol compete for alcohol dehydrogenase. Administering ethanol keeps the enzyme occupied and prevents methanol from being converted to toxic formaldehyde and formic acid.

Noncompetitive Inhibition

A noncompetitive inhibitor binds to a site on the enzyme that is distinct from the active site — an allosteric site. It can bind to both the free enzyme and the enzyme-substrate complex with equal affinity. Binding does not prevent substrate binding, but it distorts the enzyme's conformation so that catalysis is impaired.

Key characteristics:

• Binds reversibly to an allosteric site (not the active site).
• Cannot be overcome by increasing substrate concentration — the inhibitor acts regardless of [S].
• Effect on kinetics: Decreases V_max (fewer functional enzyme molecules) but does NOT change K_m (substrate affinity of the remaining functional enzyme is unchanged).
• On a Lineweaver-Burk plot, noncompetitive inhibition produces lines that intersect on the x-axis (same K_m, different V_max).

Biological examples:

• Heavy metals (Pb²⁺, Hg²⁺) can act as noncompetitive inhibitors by binding to sulfhydryl groups far from the active site and altering conformation.
• Some ATP-competitive kinase inhibitors in cancer therapy show mixed or noncompetitive behavior.

Allosteric Regulation

Allosteric regulation is the control of enzyme activity through the binding of a regulatory molecule (an effector or modulator) at a site other than the active site — the allosteric site (Greek allos = other, stereos = shape). Allosteric regulation is the most common and sophisticated mechanism of metabolic control.

Allosteric enzymes are typically multi-subunit proteins (oligomers) that display cooperativity (see below). They do not follow Michaelis-Menten kinetics; instead, they produce sigmoidal (S-shaped) velocity-vs.-substrate curves.

Allosteric activators bind and stabilize the enzyme in the high-affinity R state (relaxed), shifting the curve leftward — less substrate is needed to reach a given velocity. Allosteric inhibitors bind and stabilize the low-affinity T state (tense), shifting the curve rightward.

Key characteristics:

• Binds at an allosteric site, structurally and spatially distinct from the active site.
• Does NOT resemble the substrate — structural mimicry is not required.
• Modulates the enzyme's affinity for substrate (K_m) and/or catalytic efficiency (k_cat) through conformational change.
• The effect is saturable and reversible.
• Provides a mechanism for feedback control (see Feedback Inhibition below).

Biological examples:

• Phosphofructokinase-1 (PFK-1) — the key regulatory enzyme of glycolysis — is allosterically inhibited by ATP (when energy is abundant) and activated by AMP (when energy is low). Citrate also inhibits PFK-1.
• Aspartate transcarbamoylase (ATCase) — a classic example — is inhibited by CTP (the end product of the pyrimidine biosynthesis pathway) and activated by ATP.

Cooperativity

Cooperativity is a special case of allosteric behavior displayed by enzymes with multiple subunits, where the binding of a substrate molecule to one active site influences the substrate-binding affinity of the remaining active sites.

Positive cooperativity: The binding of the first substrate molecule increases the affinity of the remaining active sites for subsequent substrate molecules. This produces the sigmoidal velocity curve characteristic of allosteric enzymes. Hemoglobin (though not an enzyme, it is the classic example) displays positive cooperativity in oxygen binding. Among enzymes, ATCase shows positive cooperativity for aspartate binding.

Negative cooperativity: The binding of the first substrate decreases the affinity of remaining sites (rare; produces a less steep curve).

Homotropic regulation: The substrate itself is the allosteric modulator. The binding of substrate at one active site influences substrate binding at other active sites — this is what cooperativity describes.

Heterotropic regulation: A different molecule (not the substrate) binds at an allosteric site and modulates activity. Allosteric activators and inhibitors are heterotropic effectors.

The MWC (Monod-Wyman-Changeux) model (also called the concerted model) explains cooperativity by proposing that all subunits of an oligomeric enzyme exist in the same conformational state (all T or all R). Substrate binds preferentially to the R state. As substrate binds and shifts individual subunits to R, the equilibrium between T and R shifts for the entire complex, increasing the probability that the remaining subunits will also adopt the R state. The KNF (Koshland-Némethy-Filmer) model (sequential model) proposes that subunits change conformation one at a time upon substrate binding, with each binding event influencing the next.

Feedback Inhibition

Feedback inhibition (end-product inhibition) is a specific and biologically critical form of allosteric regulation. In a metabolic pathway, the final product of the pathway inhibits an enzyme that catalyzes an early, committed step:

A → B → C → D → E  (final product)
     ↑           │
     └───────────┘
     E inhibits enzyme 1

This elegant mechanism prevents the cell from overproducing a metabolite. When E accumulates to sufficient levels, it binds to an allosteric site on the first committed enzyme of its own biosynthetic pathway, shutting down production. When E levels drop (because it is being consumed), the inhibition is relieved and synthesis resumes.

Feedback inhibition is:

• Rapid — no new protein synthesis or degradation required.
• Reversible — inhibition is lifted when product concentration falls.
• Efficient — prevents wasteful expenditure of energy and precursors on unnecessary metabolites.
• Common — virtually every biosynthetic pathway is regulated by feedback inhibition at one or more points.

Biological examples:

• Isoleucine inhibits threonine deaminase, the first committed step in isoleucine biosynthesis from threonine.
• CTP inhibits ATCase in pyrimidine biosynthesis.
• Cholesterol inhibits HMG-CoA reductase (the target of statins) in cholesterol biosynthesis.

Comparison Table: Competitive vs Noncompetitive vs Allosteric Regulation

How It Works

The Logic of Enzymatic Catalysis

Enzyme function can be understood as a cascade of physical and chemical principles:

1. Binding energy pays for E_a reduction. The multiple weak interactions that form between enzyme and substrate (hydrogen bonds, ionic bonds, hydrophobic contacts) release binding energy. This energy is used to distort the substrate toward the transition-state geometry — effectively paying for part of the activation barrier.

1. Proximity and orientation substitute for random collisions. In free solution, reactants must collide with correct orientation and sufficient energy. An enzyme binds its substrates and holds them in the optimal orientation — converting an intermolecular reaction into an effectively intramolecular one with a vastly higher effective concentration.

1. Catalytic groups are precisely positioned. Amino acid side chains in the active site are held in exact positions to donate or accept protons, form transient covalent intermediates, or stabilize developing charges. This precision is impossible in free solution.

1. The transition state is selectively stabilized. An enzyme does not simply bind the substrate tightly — it binds the transition state even more tightly. The active site is complementary to the transition state, not the ground-state substrate. This is why transition-state analogs are such powerful inhibitors: they exploit the enzyme's evolved preference for the transition-state geometry.

1. Allostery provides control. By evolving separate binding sites for regulatory molecules and linking them to the active site through conformational change, enzymes become switchable. The cell can tune metabolic flux in real time without synthesizing or degrading enzymes.

Why ΔG Matters and Why E_a Matters

A common source of confusion is the relationship between thermodynamics and kinetics:

• Thermodynamics (ΔG) tells you whether a reaction can happen. A negative ΔG means the reaction is spontaneous (exergonic); a positive ΔG means it is not (endergonic).
• Kinetics (E_a) tells you how fast a spontaneous reaction will happen. A large E_a means a slow reaction; a small E_a means a fast one.
• Enzymes affect kinetics only. They lower E_a. They do not touch ΔG. A reaction with ΔG > 0 remains nonspontaneous no matter how much enzyme is present. An enzyme cannot drive a reaction uphill.

This is why cells couple endergonic reactions (e.g., glucose phosphorylation, ΔG = +13.8 kJ/mol) to ATP hydrolysis (ΔG ≈ −30.5 kJ/mol). The combined ΔG is negative, making the coupled process spontaneous. The enzyme then lowers E_a so the coupled reaction proceeds at a useful rate.

Biological / Medical Relevance

• Pharmacology: A large fraction of pharmaceutical drugs are enzyme inhibitors. Statins (competitive inhibition of HMG-CoA reductase), ACE inhibitors (blood pressure), proton-pump inhibitors (omeprazole), COX-2 inhibitors (inflammation), and reverse transcriptase inhibitors (HIV) all work by inhibiting specific enzymes. Understanding inhibition mechanisms is central to rational drug design.
• Methanol and ethylene glycol poisoning: Treated with ethanol or fomepizole, which competitively inhibit alcohol dehydrogenase, preventing conversion to toxic metabolites.
• Heavy metal toxicity: Pb²⁺, Hg²⁺, and other heavy metals poison enzymes by binding to sulfhydryl groups, causing noncompetitive inhibition and denaturation. Lead poisoning specifically inhibits enzymes in heme synthesis (δ-aminolevulinic acid dehydratase and ferrochelatase), causing anemia.
• Cyanide poisoning: Cyanide (CN⁻) binds to the iron in cytochrome c oxidase (Complex IV of the electron transport chain), noncompetitively inhibiting mitochondrial respiration — rapidly fatal because ATP production halts.
• Enzyme diagnostics: Measuring serum enzyme levels is standard clinical practice. Elevated troponin (heart attack), ALT/AST (liver damage), amylase/lipase (pancreatitis), and creatine kinase (muscle damage) all reflect enzymes leaking from damaged cells.
• Genetic enzyme deficiencies: Inborn errors of metabolism result from mutations in enzyme genes. Phenylketonuria (PKU) — defective phenylalanine hydroxylase. Lactose intolerance — reduced lactase activity. G6PD deficiency — impaired pentose phosphate pathway; hemolytic anemia triggered by oxidative stress.
• Thermophilic enzymes in biotechnology: Taq DNA polymerase (from Thermus aquaticus) enabled PCR because it is stable at the high temperatures (95°C) required for DNA denaturation. Enzymes from extremophiles are widely used in industrial processes.
• Feedback inhibition and drug targets: Cancer cells often dysregulate feedback inhibition to sustain uncontrolled biosynthesis. Understanding allosteric control points offers therapeutic targets — for instance, inhibiting the allosterically regulated enzymes of nucleotide biosynthesis to slow tumor proliferation.

Common Misconceptions and Exam Traps

• Misconception: Enzymes provide energy to drive reactions. Reality: Enzymes do not provide energy. They lower activation energy. ΔG is unchanged.
• Exam trap: "The enzyme lowers ΔG so the reaction can proceed." Wrong. The enzyme lowers E_a. ΔG is determined solely by the difference in free energy between reactants and products — it is a state function, path-independent, and an enzyme cannot alter it.
• Misconception: Enzymes change the equilibrium constant (K_eq). Reality: Enzymes increase the rates of forward and reverse reactions equally. K_eq (which equals k_forward / k_reverse) is unchanged. Equilibrium position depends only on ΔG.
• Exam trap: "A noncompetitive inhibitor can be overcome by adding more substrate." Wrong. This is true of competitive inhibition, not noncompetitive. Noncompetitive inhibitors bind at a different site; no amount of substrate can displace them.
• Misconception: The induced-fit model means the substrate changes shape to fit the enzyme. Reality: The enzyme changes shape upon substrate binding. The substrate may also be distorted, but the defining feature is the conformational change in the enzyme.
• Exam trap: Confusing cofactors and coenzymes. Cofactors = inorganic (minerals, metals). Coenzymes = organic (often vitamins). The apoenzyme + cofactor/coenzyme = holoenzyme.
• Misconception: Denaturation means the protein has been destroyed or broken into pieces. Reality: The peptide bonds are intact. Denaturation involves only the disruption of noncovalent interactions. The primary structure remains unchanged — the protein is just unfolded.
• Misconception: All enzymes are proteins. Reality: Most are. However, certain RNA molecules (ribozymes) also have catalytic activity — for example, the peptidyl transferase activity of the ribosome is catalyzed by rRNA, not protein. These are the exception, not the rule.
• Exam trap: "The optimal temperature for human enzymes is 37°C because above this temperature, molecules move too fast to bind." Wrong. Above ~40–45°C, thermal energy begins to denature the enzyme by disrupting the weak interactions that maintain its folded structure. The issue is structural integrity, not collision speed.
• Misconception: Allosteric inhibitors work the same way as competitive inhibitors. Reality: Allosteric inhibitors bind at sites distinct from the active site and work through conformational change. They do not compete with the substrate for the active site.